Sign in

Dennis R. DeLoach, III

Director at BayFirst Financial
Board

About Dennis R. DeLoach, III

Dennis R. “Rep” DeLoach, III, age 50, is an independent director of BayFirst Financial Corp. and a partner at DeLoach, Hofstra & Cavonis, P.A. in Seminole, Florida; he graduated from Mercer University (1996) and Mercer University Law School (1999), is Board Certified by the Florida Bar in Elder Law, and joined the BayFirst Board in 2020 . He is described as a frequent CLE speaker to Florida attorneys, with qualifications to serve based on his legal experience .

Past Roles

OrganizationRoleTenureCommittees/Impact
DeLoach, Hofstra & Cavonis, P.A.PartnerNot disclosedBoard Certified Elder Law; frequent CLE speaker

External Roles

OrganizationRoleTenureNotes
None disclosedNo other public company directorships disclosed for Mr. DeLoach

Board Governance

  • Independence: The Board determined the Compensation Committee members, including Mr. DeLoach, are independent under Nasdaq rules and qualify as “nonemployee directors” under SEC rules . The Board states a majority of directors are independent; named non-independent directors do not include Mr. DeLoach .
  • Committees and roles:
    • Compensation Committee: Chair .
    • Audit & Risk Management Committee: Member; named in the Audit Committee report .
  • Bank Board: Each Company director except Mark S. Berset also serves on the Bank’s Board; thus Mr. DeLoach is a Bank director .
  • Attendance: In 2024, the Board held nine meetings and all directors attended at least 75% of Board and applicable committee meetings .
  • Consultant independence: Compensation Committee retained Pearl Meyer; independence assessed with no conflicts identified .

Committee Assignments

NameAudit & Risk ManagementCompensationCorporate Social ResponsibilityExecutiveNominating
Dennis R. DeLoach, IIIMember Chair

Fixed Compensation

  • Director fee schedule:
    • Board meeting fee: $1,500 per Company Board meeting; $1,500 per separate Bank Board meeting .
    • Chair annual retainers: Board/Bank Board Chair $22,500; Audit Chair $10,000; Nominating Chair $7,500; Bank ALCO Chair $7,500; Compensation Chair $7,500; CSR Chair $5,000 .
    • Committee meeting fees: $500 per meeting for Audit, Compensation, CSR; Bank Credit & Loan, Bank ALCO, Bank Compliance Committees .

2024 Director Compensation (Mr. DeLoach)

MetricFY 2024
Cash Fees Earned$34,500
Stock Awards$10,823
Total$45,323

Performance Compensation

  • Director equity awards are granted under the Amended and Restated 2017 Equity Incentive Plan (EIP) which permits stock options, restricted stock, and RSUs; the number of shares reserved equals 15% of shares outstanding, capped at 1,500,000 shares .
  • Equity Grant Timing Policy: The Board is developing a policy to grant equity only during open trading windows and when not in possession of MNPI, intended to avoid “spring-loading”; recent grants occurred four days after the year-end earnings press release, consistent with prior practice .

Performance Metrics Tied to Director Compensation

MetricDisclosed for Directors?
TSR percentileNot disclosed
Revenue/EBITDA goalsNot disclosed
ESG goalsNot disclosed
Discretionary modifiersNot disclosed

Executive AIP metrics and targets are disclosed for NEOs (cash bonus up to 100%/70%/50% of base for CEO/President/CFO based on objective and subjective criteria), but no performance metrics are specified for non-employee director compensation .

Other Directorships & Interlocks

PersonExternal Public BoardsInterlocks/Related Notes
Dennis R. DeLoach, IIINone disclosed Compensation Committee independence affirmed; consultant Pearl Meyer engaged without conflicts

Expertise & Qualifications

  • Legal expertise: Board Certified Elder Law; partner in a Florida law firm; frequent CLE speaker .
  • Board contribution: Qualifications cited as legal experience relevant to Board service .

Equity Ownership

  • Prohibitions: Hedging and short selling prohibited for directors, officers, and employees under Insider Trading and Confidentiality Policy .
  • Section 16(a) compliance: No delinquent filings reported for Mr. DeLoach in 2024 (one late Form 4 noted for another director) .

Beneficial Ownership (as of March 24, 2025)

HolderShares OwnedRight to Acquire (within 60 days)Percent of Outstanding
Dennis R. DeLoach, III35,213.14 11,550.00 1.13% (based on 4,129,027 shares)

Governance Assessment

  • Positives:

    • Independent director with legal expertise; chairs the Compensation Committee and serves on Audit, supporting Board effectiveness in pay and financial oversight .
    • Good engagement: 2024 attendance threshold met across Board/committees; nine Board meetings held .
    • Alignment: Holds a meaningful personal stake (1.13% beneficial ownership including rights to acquire), and hedging/short-selling are prohibited company-wide .
    • Process integrity: Compensation Committee uses an independent consultant (Pearl Meyer) with no conflicts; Board developing an Equity Grant Timing Policy to avoid spring-loading .
  • Watch items:

    • Related-party transactions exist involving other directors (lease with entity affiliated with Dr. Politis’ family; insurance purchases from entities owned by Berset family) and $9.26 million in loans to directors/executives/immediate families; while policy requires disinterested approval and market terms, these arrangements elevate conflict risk contextually—no DeLoach-specific related-party transactions are disclosed .
    • Director ownership guidelines for non-employee directors are not disclosed, limiting assessment of guideline compliance for Mr. DeLoach (no guideline language identified in proxy).
  • RED FLAGS (none specific to Mr. DeLoach identified):

    • No disclosed pledging/hedging by Mr. DeLoach; hedging broadly prohibited .
    • No Section 16(a) delinquency reported for Mr. DeLoach .
    • No director-specific related-party transactions or consulting arrangements with Mr. DeLoach’s law firm disclosed .